BC Innovations | Oct 24, 2017
Distillery Therapeutics


INDICATION: Atherosclerosis Patient sample and mouse studies suggest inhibiting CAMK2G could help treat atherosclerosis. In arterial plaque-associated macrophages from patients with carotid artery stenosis, levels of activated CAMK2G were higher in patients with stroke symptoms...
BC Innovations | Jun 25, 2015
Distillery Techniques

Techniques: Five loci associated with susceptibility to psoriasis

Biomarkers TECHNOLOGY: SNPs Genetic studies identified five new susceptibility loci for psoriasis. Genomewide association studies in 10,262 patients with psoriasis and 21,871 controls identified associations between SNPs on five loci and the disease. Three of...
BC Innovations | Jan 9, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Calcium calmodulin-dependent protein kinase IIg (CAMK2G) Mouse studies suggest inhibiting CAMK2G could help improve hyperglycemia and insulin sensitivity in patients with type 2...
Items per page:
1 - 3 of 3